WallStreetZenWallStreetZen

NASDAQ: FLNA
Filana Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for FLNA

Based on 1 analyst offering 12 month price targets for Filana Therapeutics Inc

Min Forecast
$8.00+332.43%
Avg Forecast
$8.00+332.43%
Max Forecast
$8.00+332.43%

Should I buy or sell FLNA stock?

Based on 1 analyst offering ratings for Filana Therapeutics Inc.

Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although FLNA's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates FLNA as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their FLNA stock forecasts and price targets.

FLNA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-10-06

1 of 1

Forecast return on equity

Is FLNA forecast to generate an efficient return?

Company
N/A
Industry
68.5%
Market
178.91%

Forecast return on assets

Is FLNA forecast to generate an efficient return on assets?

Company
N/A
Industry
31.48%

FLNA earnings per share forecast

What is FLNA's earnings per share in the next 2 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$1.24
Avg 2 year Forecast
$9.18

FLNA revenue forecast

What is FLNA's revenue in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
$0.0
Avg 2 year Forecast
$0.0
Avg 3 year Forecast
$0.0

FLNA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
FLNA$1.85$8.00+332.43%Strong Buy
SPRB$64.36$203.25+215.80%Buy
FBIO$2.92$17.00+482.19%Buy
MAIA$1.44N/AN/A
ANIX$2.59$10.00+286.10%Strong Buy
View Top Biotech Stocks

Filana Therapeutics Stock Forecast FAQ

Is Filana Therapeutics Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: FLNA) stock is to Strong Buy FLNA stock.

Out of 1 analyst, 1 (100%) are recommending FLNA as a Strong Buy, 0 (0%) are recommending FLNA as a Buy, 0 (0%) are recommending FLNA as a Hold, 0 (0%) are recommending FLNA as a Sell, and 0 (0%) are recommending FLNA as a Strong Sell.

If you're new to stock investing, here's how to buy Filana Therapeutics stock.

What is FLNA's earnings growth forecast for 2026-2027?

(NASDAQ: FLNA) Filana Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.88%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 35.77%.

Filana Therapeutics's earnings in 2026 is -$90,973,000.On average, 3 Wall Street analysts forecast FLNA's earnings for 2026 to be -$60,114,346, with the lowest FLNA earnings forecast at -$57,756,920, and the highest FLNA earnings forecast at -$61,882,415.

In 2027, FLNA is forecast to generate $443,466,485 in earnings, with the lowest earnings forecast at $426,075,643 and the highest earnings forecast at $456,509,617.

What is FLNA's revenue growth forecast for 2026-2028?

(NASDAQ: FLNA) Filana Therapeutics's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 35.26%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.29%.

Filana Therapeutics's revenue in 2026 is $0.On average, 3 Wall Street analysts forecast FLNA's revenue for 2026 to be $0, with the lowest FLNA revenue forecast at $0, and the highest FLNA revenue forecast at $0. On average, 3 Wall Street analysts forecast FLNA's revenue for 2027 to be $0, with the lowest FLNA revenue forecast at $0, and the highest FLNA revenue forecast at $0.

In 2028, FLNA is forecast to generate $0 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $0.

What is FLNA's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: FLNA) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 31.48%.

What is FLNA's Price Target?

According to 1 Wall Street analyst that have issued a 1 year FLNA price target, the average FLNA price target is $8.00, with the highest FLNA stock price forecast at $8.00 and the lowest FLNA stock price forecast at $8.00.

The Wall Street analyst predicted that Filana Therapeutics's share price could reach $8.00 by Oct 6, 2026. The average Filana Therapeutics stock price prediction forecasts a potential upside of 332.43% from the current FLNA share price of $1.85.

What is FLNA's Earnings Per Share (EPS) forecast for 2026-2027?

(NASDAQ: FLNA) Filana Therapeutics's current Earnings Per Share (EPS) is -$1.88. On average, analysts forecast that FLNA's EPS will be -$1.24 for 2026, with the lowest EPS forecast at -$1.20, and the highest EPS forecast at -$1.28. In 2027, FLNA's EPS is forecast to hit $9.18 (min: $8.82, max: $9.45).

What is FLNA's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: FLNA) forecast ROE is N/A, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.